BeiGene, Ltd. (688235.SS)

CNY 162.8

(-1.08%)

Market Cap (In CNY)

143.97 Billion

Revenue (In CNY)

2.45 Billion

Net Income (In CNY)

-881.7 Million

Avg. Volume

1.69 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
98.5-207.98
PE
-
EPS
-
Beta Value
0.63
ISIN
CNE100005XT6
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Mr. John V. Oyler
Employee Count
-
Website
http://www.beigene.com
Ipo Date
2021-12-15
Details
BeiGene Ltd. is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.